0519

Welcome to the May issue! Medical cannabis and scientific research around cannabinoids is booming, but what does this mean for the pharma industry? Read our feature to find out. Meanwhile, Upfront explores the bioactivity of Actinobacteria found within brown seaweed, and how will the industry shape up over the next five years with an infographic. Heather Zenk argues that blockchain could be one solution to the saleable returns verification aspect of the US Drug Supply Chain Security Act, in In My View; and we tell the story of IPEC's humble beginnings with David Schoneker in Best Practice. Finally, we Sit Down With Robert S. Langer, Pediatrics Polymath, Jinling Chen.

Email*

Choose a password

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

I want to receive an alert when the next issue is available online

Articles featured in this issue

Manufacture Small Molecules

Small, But Never Forgotten

05/13/2019 | Stephanie Vine

A new publication will give the small molecule manufacturing community the attention and praise it deserves. Meet The Small Molecule Manufacturer.

Discovery & Development Drug Discovery

Solutions In... Nanoparticles

05/28/2019 | Maryam Mahdi

Why are spherical nucleic acids so exciting for drug development?

Business & Regulation Trends & Forecasts

2023: Prices and Predictions

06/05/2019 | Maryam Mahdi

How will the industry shape up over the next five years?

Discovery & Development Drug Discovery

Treasures of the Deep

05/13/2019 | Maryam Mahdi

Could aquatic bacteria hold the keys to bolstering our drug pipelines?

Business & Regulation Biosimilars

Business in Brief

05/09/2018 | Stephanie Vine

The latest business news and views in pharma.

Business & Regulation Contract Manufacturing Services

(Block)chain Reaction

05/07/2019 | Heather Zenk

Blockchain could be one solution to the saleable returns verification aspect of the US’ Drug Supply Chain Security Act.

Discovery & Development Drug Discovery

The Killer Combo

05/28/2019 | Anthony Coates

Can synergistic combinations rejuvenate existing antibiotics in the fight against antibiotic resistance?

Discovery & Development Formulation

Choosing the Right Excipients for the Right Job

07/01/2019 | Rob Harris

When it comes to formulation, many choices should be carefully considered – and regulators expect excipient selection to be justified.

Manufacture Trends & Forecasts

Under Construction: Pharma's Cannabinoid Bid

05/28/2019 | James Strachan

The cannabis business is booming as century-old legal conventions restricting use begin to unravel. Can pharma ride the wave?

Manufacture Bioprocessing - Upstream & Downstream

Built on Innovation

05/13/2019 | Sponsored by Schott

Innovation in glass continues to be a key enabler for allowing pharma manufacturers to make better, safer products for patients.

Business & Regulation Standards & Regulation

The IPEC Story: Promoting Ingredients for Success

06/05/2019 | With David Schoneker

High quality excipients make all the difference to the drug development process. And yet, for years, excipients were often overlooked by the industry.